Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:771-777
Published online before print March 6, 2006, doi: 10.1161/01.HYP.0000209642.11448.e0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/4/771    most recent
01.HYP.0000209642.11448.e0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R. D.
Related Collections
Right arrow Clinical Studies
Right arrowRelated Article

(Hypertension. 2006;47:771.)
© 2006 American Heart Association, Inc.


Original Articles

Value of Noninvasive Hemodynamics to Achieve Blood Pressure Control in Hypertensive Subjects

Ronald D. Smith; Pavel Levy; Carlos M. Ferrario for the Consideration of Noninvasive Hemodynamic Monitoring to Target Reduction of Blood Pressure Levels Study Group

From the Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston-Salem, NC.

Correspondence to Carlos Ferrario, Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1032. E-mail cferrari{at}wfubmc.edu

Abnormal hemodynamics play a central role in the development and perpetuation of high blood pressure. We hypothesized that hypertension therapy guided by noninvasive hemodynamics with impedance cardiography could aid primary care physicians in reducing blood pressure more effectively. Uncontrolled hypertensive patients on 1 to 3 medications were randomized by 3:2 ratio to either a standard arm or hemodynamic arm that used impedance cardiography (BioZ, CardioDynamics). Each patient completed 5 study visits with a 2-week washout period followed by 3 months of treatment. A total of 164 patients from 11 centers completed the study, 95 in the standard arm and 69 in the hemodynamic arm. At baseline and after washout, there were no differences between arms in number of medications or demographic, blood pressure, or hemodynamic characteristics. Systolic blood pressure reductions in the hemodynamic arm were greater from baseline (19 mm Hg versus 11 mm Hg; P<0.01) and after washout (25 mm Hg versus 19 mm Hg; P<0.05). Diastolic blood pressure reductions were also greater in the hemodynamic arm from baseline (12 mm Hg versus 5 mm Hg; P<0.001) and after washout (17 mm Hg versus 10 mm Hg; P<0.001). The hemodynamic arm achieved goal blood pressure (<140/90 mm Hg) more frequently (77% versus 57%; P<0.01) and a more aggressive blood pressure level (<130/85 mm Hg) more frequently (55% versus 27%; P<0.0001). These study results indicate that antihypertensive therapy guided by impedance cardiography in uncontrolled hypertensive patients on ≥1 medications is more effective than standard care.


Key Words: hemodynamics • cardiac output • vascular resistance • hypertension, arterial • hypertension, essential • blood pressure


Related Article:

Noninvasive Hemodynamic Measurements: An Important Advance in Individualizing Drug Therapies for Hypertensive Patients
John M. Flack
Hypertension 2006 47: 646-647. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Therapeutic Advances in Cardiovascular DiseaseHome page
C. M. Ferrario, J. Basile, W. Bestermann, E. Frohlich, M. Houston, D. T. Lackland, R. D. Smith, and D. L. Wise
Review: The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension
Therapeutic Advances in Cardiovascular Disease, December 1, 2007; 1(2): 113 - 118.
[Abstract] [PDF]


Home page
HypertensionHome page
S. J. Mann
Reduction of Blood Pressure Levels Study Group
Hypertension, November 1, 2006; 48(5): e104 - e104.
[Full Text] [PDF]


Home page
HypertensionHome page
J. M. Flack
Noninvasive Hemodynamic Measurements: An Important Advance in Individualizing Drug Therapies for Hypertensive Patients
Hypertension, April 1, 2006; 47(4): 646 - 647.
[Full Text] [PDF]